Gene · 965
Papers4,043
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 4,043
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma. | PLoS One | 2024 | 38306361 | PubTator, text mining | PubMed |
| Research Advances in Fusion Protein-Based Drugs for Diabetes Treatment. | Diabetes Metab Syndr Obes | 2024 | 38288338 | PubTator, text mining | PubMed |
| Plasma cell leukemia with soft tissue involvement; reporting a rare case. | Leuk Res Rep | 2024 | 38283701 | PubTator, text mining | PubMed |
| Revolutionizing cancer care strategies: immunotherapy, gene therapy, and molecular targeted therapy. | Mol Biol Rep | 2024 | 38281269 | PubTator, text mining | PubMed |
| Unexpected chronic lymphocytic leukemia B cell activation by bisphosphonates. | Cancer Immunol Immunother | 2024 | 38280019 | PubTator, text mining | PubMed |
| A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines. | Cancers (Basel) | 2024 | 38254823 | PubTator, text mining | PubMed |
| Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas. | Cancers (Basel) | 2024 | 38254810 | PubTator, text mining | PubMed |
| Application of the Peroxidase‒like Activity of Nanomaterials for the Detection of Pathogenic Bacteria and Viruses. | Int J Nanomedicine | 2024 | 38250191 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing in melanoma: what have we learned so far? | EBioMedicine | 2024 | 38241976 | PubTator, text mining | PubMed |
| Pure white cell aplasia before and after thymectomy in the rare conundrum of thymoma: A case report and review of the literature. | Medicine (Baltimore) | 2024 | 38241556 | PubTator, text mining | PubMed |
| Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8+ clonal effector and CAR T-cell function while promoting a senescence-associated phenotype. | Cancer Immunol Immunother | 2024 | 38231344 | PubTator, text mining | PubMed |
| Molecular prognostic of nine parthanatos death-related genes in glioma, particularly in COL8A1 identification. | J Neurochem | 2024 | 38225203 | PubTator, text mining | PubMed |
| Plasmablastic Lymphoma. A State-of-the-Art Review: Part 1-Epidemiology, Pathogenesis, Clinicopathologic Characteristics, Differential Diagnosis, Prognostic Factors, and Special Populations. | Mediterr J Hematol Infect Dis | 2024 | 38223486 | PubTator, text mining | PubMed |
| Multiple circulating forms of neprilysin detected with novel epitope-directed monoclonal antibodies. | Cell Mol Life Sci | 2024 | 38217709 | PubTator, text mining | PubMed |
| The Plasticity of Immune Cell Response Complicates Dissecting the Underlying Pathology of Multiple Sclerosis. | J Immunol Res | 2024 | 38213874 | PubTator, text mining | PubMed |
| Current Challenges in Chimeric Antigen Receptor T-cell Therapy in Patients With B-cell Lymphoid Malignancies. | Ann Lab Med | 2024 | 38205527 | PubTator, text mining | PubMed |
| Cancer vaccines in the clinic. | Bioeng Transl Med | 2024 | 38193112 | PubTator, text mining | PubMed |
| Neoadjuvant CD40 Agonism Remodels the Tumor Immune Microenvironment in Locally Advanced Esophageal/Gastroesophageal Junction Cancer. | Cancer Res Commun | 2024 | 38181044 | PubTator, text mining | PubMed |
| Association of CD58 rs12044852 and rs2300747 polymorphisms with the risk of multiple sclerosis: A systematic review and meta-analysis. | Mult Scler Relat Disord | 2024 | 38176285 | PubTator, text mining | PubMed |
| Improved outcomes of localized diffuse large B-cell lymphoma at the Waldeyer ring in comparison to the sinonasal area in the rituximab era. | Cancer Med | 2024 | 38148602 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/965/papers?page=7